Pharmaceutical Science
A section of Life (ISSN 2075-1729).
Section Information
This section of the journal Life aims to rapidly publish contributions related to pharmaceutical science. We encourage the submission of manuscripts that report significant advances in those fields. Topics include, but are not limited to, the following:
- pharmaceutical technology, pharmaceutics, novel drug delivery, biopharmaceutics, pharmacokinetics
- basic and clinical pharmacology, toxicology
- medicinal chemistry, computational chemistry and molecular drug design, pharmaceutical and biomedicinal analysis
- pharmacogenetics, pharmacogenomics
- epigenetic drugs, pharmacoepigenetics
- biotechnological products
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Cancer Treatment and Drug Resistance: 2nd Edition (Deadline: 20 July 2025)
- Advances in 5-Aminolevulinic Acid Applications in Medical and Healthcare (Deadline: 29 July 2025)
- Transformative Frontiers in Mental Health Treatment: Advances in Neuropsychopharmacology (Deadline: 30 July 2025)
- What Is New in Psychiatry and Psychopharmacology—2nd Edition (Deadline: 31 July 2025)
- Ion Channels and Neurological Disease: 2nd Edition (Deadline: 31 July 2025)
- Inflammation and Natural Products: 2nd Edition (Deadline: 31 July 2025)
- Natural Bioactives: Exploring Their Therapeutic Potential—2nd Edition (Deadline: 20 August 2025)
- Innovative Drug Development: Balancing Efficacy and Toxicity in Novel Pharmaceuticals (Deadline: 31 August 2025)
- The Drug Development for Neurodegenerative Diseases (Deadline: 31 August 2025)
- Therapeutic Effects of Natural Products on Human Diseases: 2nd Edition (Deadline: 27 October 2025)
- Role of Machine and Deep Learning in Drug Screening (Deadline: 29 October 2025)
- Therapeutic Approaches of Natural Products in Health and Disease (Deadline: 31 October 2025)
- Unlocking New Biochemical Pathways: A Bridge for Drug Development in Human and Animal Diseases (Deadline: 31 October 2025)
- Natural Products for the Management of Acute and Chronic Kidney Disease (Deadline: 31 October 2025)
- Plant-Derived Natural Products and Their Biomedical Properties: 2nd Edition (Deadline: 15 November 2025)
- From Prediction to Experimental Assays of More Selective and Cleaner Bioactive Synthetics: A Systemic View (Deadline: 25 November 2025)
- Pharmacokinetic and Pharmacogenetic Approaches in Personalized Medicine (Deadline: 30 November 2025)
- Synthesis and Evaluation of Novel Anticancer and Anti-Inflammatory Agents (Deadline: 30 November 2025)
- Characterization, Bioactivity Evaluation and Utilization of Plant Polysaccharides (Deadline: 31 December 2025)
- Bioactive Compounds for Medicine and Health (Deadline: 31 December 2025)
- Biochemical Modulators in Chronic Diseases: The Antioxidant/Anti-Inflammatory Interdependence—2nd Edition (Deadline: 31 December 2025)
- Update on Clinical Pharmacology (Deadline: 31 December 2025)
- Green Medicine: Unraveling the Medicinal Effects of Plant Extracts and Functional Foods (Deadline: 24 March 2026)
- Therapeutic Innovations from Plants and Their Bioactive Extracts (Deadline: 26 March 2026)
- Innovations, Utilization, and Safety of Psychiatric Drugs: Current Trends and Future Directions (Deadline: 30 March 2026)
- Biological Insights into Drug Safety for Vulnerable Populations (Deadline: 30 March 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
